Cyclosporine Completed Phase 3 Trials for Keratoconjunctivitis Sicca Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02688556Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca